Dataset Viewer

The dataset viewer is not available because its heuristics could not detect any supported data files. You can try uploading some data files, or configuring the data files location manually.

A Federal Bodily-Integrity Framework for Non-Consensual Genital Procedures

Status: Working draft, v0.3 (November 2026) Scope: U.S. federal law and policy only Author: Ashley. Drafted with Claude (Anthropic), which conducted the research and wrote the text under Ashley's direction; Ashley set the scope, directed revisions, and is responsible for the final content.

Not legal advice. This is a research and policy proposal. Not every claim has been checked to the same standard. §13 (How the citations were checked) lists which ones were checked with web search and which come only from the AI's background knowledge. Check the primary sources before citing this in any legal or legislative setting.


Abstract

U.S. federal law currently treats non-consensual, non-therapeutic genital procedures on minors very differently depending on the child's sex, the reason for the procedure, and the political context. Female genital mutilation is a federal crime. As of 2026, federal health-funding rules restrict genital and other interventions for gender transition in minors, but expressly exempt interventions on intersex children. Routine infant male circumcision is mostly unregulated at the federal level, and there is no federal medical-society guideline currently in force for it.

We propose one sex-neutral principle: genital tissue of a person who cannot consent should not be permanently altered unless that is medically necessary. We then ask how far the federal government can carry out that principle within its enumerated powers, the Bill of Rights, and the Religious Freedom Restoration Act (RFRA). Our conclusion is that federal power is strongest over federal facilities and federally funded care, moderate in criminal law with a commerce nexus, and weakest where the framework collides with religious practice protected by RFRA. We recommend tools in that order.


1. The problem

Four categories of procedure involve permanently altering a minor's genitals without the minor's own consent:

  1. Female genital mutilation/cutting (FGM/C)
  2. "Normalizing" surgery on intersex children (children with differences or disorders of sex development, DSD)
  3. Routine (non-therapeutic) infant male circumcision
  4. Genital surgery on minors for gender dysphoria

Federal law treats these four inconsistently (see §5). This framework does not take a position on which category is "really" mutilation. It asks what rule follows if the same principle applies to all four, and which parts of that rule the federal government can lawfully enforce.

2. Definitions

The definition is based on the procedure, not on the patient's sex or the reason for it. This is deliberate: it reduces equal-protection risk (§7.4) and keeps the rule neutral and generally applicable for free-exercise purposes (§7.3).

  • Genital procedure: any cutting, removal, excision, infibulation, or other permanent surgical alteration of the external genitalia or gonads.
  • Covered person: an individual who lacks capacity to give informed consent to the procedure because of age or incapacity. The default threshold is the age of majority. §11 discusses the mature-minor question.
  • Medically necessary: required to diagnose or treat an existing physical condition (for example malignancy, infection, obstruction, trauma, impaired urinary or reproductive function), or to prevent serious physical harm that is reasonably likely to occur before the person could consent. Necessity is judged against evidence-based clinical standards.
  • Not medically necessary: done mainly for cultural, religious, cosmetic, social-conformity, or parental-preference reasons, or for a future benefit that could equally be obtained after the person can consent.
  • Deferrable: a procedure is deferrable if waiting until the person can consent would not cause serious physical harm.

3. Ethical principles

# Principle Grounding What it does in the framework
P1 Bodily integrity Common-law battery and informed consent (Schloendorff v. Society of N.Y. Hospital, 1914; Canterbury v. Spence, 1972) Cutting a person who hasn't consented needs a justification
P2 Right to an open future Feinberg (1980) Irreversible procedures that can wait should wait for the person's own decision
P3 Necessity, not preference Beneficence and non-maleficence Separates treatment from alteration
P4 Bounded parental authority Meyer (1923), Pierce (1925), Parham v. J.R. (1979), Troxel (2000), limited by Prince v. Massachusetts (1944) Parents decide medical care by default, but not for procedures that are deferrable and not medically necessary
P5 Least restrictive means RFRA, 42 U.S.C. § 2000bb-1(b) Try information, consent rules, and funding conditions before criminal law
P6 Consistency Equal protection; Fulton (2021), Tandon (2021) Same rule regardless of sex, religion, or rationale
P7 Community-centered enforcement Public-health experience with FGM/C Prefer prevention and engagement over prosecutions that drive the practice underground

4. Tiers of procedures

Tier Description Federal response
A Medically necessary and urgent Allowed with ordinary informed consent
B Medically indicated but deferrable Allowed with safeguards: independent second opinion, documented reason for not waiting, and ethics-committee review if the patient can't participate in the decision
C Not medically necessary and deferrable Deferred until the person can consent. Enforced through funding, facility, and consent rules, not new criminal law
D Already a federal crime 18 U.S.C. § 116 (FGM of minors, with a commerce nexus). Keep and enforce it

5. Current federal landscape (as of November 2026)

Category Federal status Source
FGM/C Federal crime. 18 U.S.C. § 116 was struck down as beyond the commerce power in United States v. Nagarwala, 350 F. Supp. 3d 613 (E.D. Mich. 2018). Congress re-enacted it with an interstate/foreign-commerce element, findings, liability for parents and guardians who facilitate, and annual DOJ reporting: STOP FGM Act of 2020, Pub. L. 116-309 (Jan. 5, 2021). Transporting a minor abroad for FGM ("vacation cutting") is separately covered. [1][2][3]
Gender-related procedures on minors Executive Order 14187 (Jan. 28, 2025) declares a policy against federal support. Its funding directives are under a nationwide preliminary injunction in PFLAG v. Trump, No. 8:25-cv-00337 (D. Md.); the government's appeal is pending in the 4th Cir. A CMS final rule (Aug. 13, 2026; effective Oct. 13, 2026; 42 C.F.R. parts 441 and 457) bars federal Medicaid and CHIP payment for "sex-rejecting procedures" for minors, relying on independent Social Security Act authority. A proposed hospital Condition of Participation (CMS-3481-P, 90 FR 59463, Dec. 19, 2025) would bar such procedures in all Medicare/Medicaid hospitals; the final rule is scheduled for Dec. 2026. United States v. Skrmetti, 605 U.S. 495 (2025), applied rational-basis review to a state ban. H.R. 3492 (criminal provisions) passed the House 216–211 on Dec. 17, 2025 and is pending in Senate Judiciary. [4][5][6][7][8][9]
Intersex/DSD surgery No federal or state prohibition. News coverage of the CMS Medicaid/CHIP rule says it exempts treatment of intersex conditions and disorders of sex development (DSD) from its restriction. We could not retrieve the rule's text to confirm the exact wording; see §13. State bans on gender-affirming care also exempt intersex procedures, and H.R. 3492 does too, according to interACT's analysis. The Protect Intersex Children Act (H.R. 5730, 117th; H.R. 10426, 118th) would have made Title IV-E foster-care funding conditional on states prohibiting non-emergency genital surgery on foster children under 6. It never advanced. [11][12][13]
Infant male circumcision No federal regulation. The AAP's 2012 policy statement (benefits outweigh risks, but not recommending routine circumcision) expired in 2017 and was not reaffirmed. Some state Medicaid programs don't cover non-indicated neonatal circumcision: 12 per a 2023 review, 17 per older counts. [14][15][16]

What the table shows: a non-consensual genital procedure on a minor is currently a federal crime, restricted in funding, exempt from restriction, or unregulated, depending on the category, not on any principle that covers all four. The rest of this document applies one principle (§2–4) to all of them.

6. Federal tools, ranked by how legally secure they are

6.1 Federal facilities and personnel (most secure)

The VA, military treatment facilities and TRICARE, the Indian Health Service, the Bureau of Prisons, and other federally operated care. The federal government can set clinical policy directly here. Proposal: adopt the Tier A–D rules as agency clinical policy.

6.2 Spending Clause conditions

Medicaid/CHIP, Medicare Conditions of Participation (42 C.F.R. part 482; informed consent at §§ 482.13(b), 482.51(b)), FEHB, and Title IV-E foster care. Limits on conditions: they must be unambiguous (Pennhurst, 1981), related to the program's purpose (South Dakota v. Dole, 1987), and not coercive (NFIB v. Sebelius, 2012). Proposals:

  • No federal payment for Tier C procedures on covered persons, applied sex-neutrally across all four categories. Note that the 2026 CMS rule shows CMS believes it has the authority to make category-specific funding exclusions.
  • A Condition of Participation requiring the Tier B safeguards: documented necessity, an independent second opinion, and ethics review for patients who can't consent.
  • Title IV-E: revive the Protect Intersex Children Act model and extend it to all Tier C procedures on children in state custody. The state is the legal guardian of these children, which gives the federal interest its strongest footing.

6.3 Criminal law with a commerce element

Nagarwala shows that a statute without a jurisdictional element is vulnerable; the STOP FGM Act shows how to fix it. Any new federal crime should copy § 116(d)'s list of commerce circumstances (interstate travel, payment, communications, instruments). Proposal: no new crimes beyond Tier D. Criminal enforcement creates the biggest problems under RFRA (§7.2) and under P7.

6.4 Foreign affairs and immigration

Asylum (Matter of Kasinga, 21 I&N Dec. 357 (BIA 1996)), the transport offense in § 116, and State Department and USAID programs. Proposal: keep these as they are. They are uncontroversial and already work.

6.5 Information and research (least coercive)

CDC prevalence surveillance, AHRQ comparative-outcomes research (especially long-term outcomes of DSD surgery, where evidence is thin), model informed-consent disclosures, and clinician training grants.

6.6 Hard limit: no commandeering

Congress cannot require states to enact or enforce prohibitions (New York v. United States, 1992; Printz, 1997; Murphy v. NCAA, 2018). Every proposal that reaches states does so only as a funding condition.

7. Constitutional and statutory stress tests

7.1 Enumerated powers

Covered in §6. Facilities and spending are secure; commerce-based criminal law is secure only with a jurisdictional element.

7.2 RFRA: the main constraint on federal action

RFRA applies to all federal law and its implementation (42 U.S.C. § 2000bb-3(a)). A later federal statute escapes RFRA only if it "explicitly excludes such application by reference to this chapter" (§ 2000bb-3(b)). If a federal action substantially burdens religious exercise, the government must show a compelling interest pursued by the least restrictive means (Gonzales v. O Centro, 2006; Burwell v. Hobby Lobby, 2014).

What this means for each category:

  • FGM/C: courts have broadly accepted a compelling interest, and the practice is not one that U.S. courts have treated as protected religious exercise. Low risk.
  • Infant male circumcision (brit milah; Islamic khitan): a federal ban would almost certainly fail RFRA review. Declining to pay for a non-indicated procedure is far less likely to count as a substantial burden, because it doesn't prohibit the religious act. Consent and disclosure rules are lower risk still.
  • Option to expressly exclude RFRA: Congress could do this under § 2000bb-3(b). We do not recommend it. It would invite a First Amendment challenge, it is politically unrealistic, and it goes against P5.

7.3 Free Exercise Clause

Under Employment Division v. Smith (1990), neutral, generally applicable laws are permitted. But under Tandon and Fulton, granting a comparable secular exemption triggers strict scrutiny. This is why consistency (P6) matters legally. A rule that defers non-indicated procedures but exempts one secular category (for example cosmetic intersex surgery) while burdening religious practice is vulnerable.

7.4 Equal protection (Fifth Amendment component)

The original § 116 protected only girls. A sex-specific rule invites intermediate scrutiny (United States v. Virginia, 1996). Skrmetti held that classifying by age and medical use triggers only rational-basis review. A sex-neutral, procedure-based rule (§2) fits within Skrmetti and also avoids the sex-classification argument.

7.5 Parental rights (substantive due process)

Parham presumes parents act in their child's best interest in medical decisions; Prince allows the state to limit parental and religious authority to protect a child's health. The framework intervenes only in Tier C (deferrable and not medically necessary), the narrowest kind of intrusion, and uses funding and consent tools rather than prohibition except where Tier D already applies.

8. Applying the framework to each category

Category Tier under this framework Recommended federal tools Expected legal risk
FGM/C D Keep § 116, enforce it, collect data, community programs Low
Intersex/DSD (non-indicated, deferrable) C Funding exclusion, Condition of Participation safeguards, Title IV-E condition, outcomes research Low–moderate (parental rights)
Intersex/DSD (medically indicated) A or B Tier B safeguards Low
Routine infant male circumcision C (if no indication) Informed-consent and disclosure standards; possibly no federal payment; no ban Moderate for non-payment; high for a ban (RFRA)
Genital surgery on minors for gender dysphoria C Covered by the same sex-neutral Tier C rule; already largely restricted by 2026 CMS action Low after Skrmetti

The consistency point: current federal policy (§5) restricts category 4 and exempts category 2. The interventions are often comparable, and in both cases the child cannot consent. Under P6, the framework treats both as Tier C unless medically necessary. People who support the current policy and people who oppose it should both be able to evaluate that criterion on its own terms.

9. Sketch of model provisions (illustrative only)

Sec. 1. Definitions. (Adopt §2 of this framework.)

Sec. 2. Federal health programs. No Federal financial participation shall be available under titles XIX or XXI of the Social Security Act, and no payment shall be made under chapter 89 of title 5 or chapter 55 of title 10, for a genital procedure on a covered person that is not medically necessary and is deferrable, without regard to the sex of the covered person or the purpose of the procedure.

Sec. 3. Hospital safeguards. As a condition of participation, a hospital performing a medically indicated but deferrable genital procedure on a covered person shall (a) document the clinical indication and the reason deferral is inappropriate, (b) obtain an independent second opinion, and (c) obtain review by an ethics committee.

Sec. 4. Children in State custody. As a condition of payments under part E of title IV of the Social Security Act, a State shall prohibit genital procedures on children in foster care that are not medically necessary and are deferrable.

Sec. 5. Research and reporting. (CDC surveillance; AHRQ long-term outcomes; annual HHS report, modeled on the STOP FGM Act's DOJ reporting.)

Sec. 6. Rule of construction. Nothing in this Act creates a criminal offense, or limits 18 U.S.C. § 116 or 42 U.S.C. § 2000bb et seq.

10. Objections and responses

  • "This attacks religious freedom." The framework deliberately avoids bans on religious practice, leaves RFRA intact, and relies on funding and consent rules. §7.2 says outright that a ban would fail.
  • "Parents, not the government, should decide." Parents keep authority over every medically necessary procedure (Tiers A and B). The framework intervenes only where the decision can wait until the child can make it.
  • "Circumcision has medical benefits." Those benefits are contested, and the AAP's statement has expired. Where a real medical indication exists, the procedure is Tier A or B. Benefits that can be obtained after the person can consent count as deferrable.
  • "Intersex surgery prevents psychosocial harm." That is an empirical claim, and the long-term evidence is limited. §6.5 funds research to settle it; until then, P2 favors waiting.
  • "The categories aren't comparable." The framework doesn't claim they are morally equivalent. It claims that the same criterion, medical necessity plus deferrability, should decide each case.

11. Open questions

  1. How to operationalize "deferrable," and who bears the burden of proof.
  2. The consent threshold: age of majority, mature-minor doctrine, or a program-specific federal age.
  3. Whether non-payment counts as a "substantial burden" under RFRA. There is no square federal holding.
  4. Whether CMS's existing statutory authority stretches to a sex-neutral Tier C exclusion without new legislation.
  5. How the CMS hospital rule and the PFLAG appeal turn out, and how either affects §6.2.
  6. Evidence base: long-term outcomes of DSD surgery, and comparative outcomes of neonatal versus later circumcision.

12. Sources

  1. STOP FGM Act of 2020, Pub. L. 116-309, 134 Stat. 4922. https://www.govinfo.gov/link/plaw/116/public/309; https://www.congress.gov/bill/116th-congress/house-bill/6100
  2. United States v. Nagarwala, 350 F. Supp. 3d 613 (E.D. Mich. 2018). https://content-static.detroitnews.com/pdf/2018/US-v-Nagarwala-dismissal-order-11-20-18.pdf
  3. CRS Legal Sidebar LSB10313, Congressional Authority to Enact Criminal Law: FGM. https://www.congress.gov/crs-product/LSB10313
  4. Executive Order 14187. https://www.whitehouse.gov/presidential-actions/2025/01/protecting-children-from-chemical-and-surgical-mutilation/
  5. PFLAG v. Trump, No. 8:25-cv-00337 (D. Md.). https://clearinghouse.net/case/46028/; https://lambdalegal.org/case/pflag-v-trump/
  6. CMS final rule, Medicaid/CHIP funding prohibition, 2026-16508 (Aug. 13, 2026). https://www.federalregister.gov/documents/2026/08/13/2026-16508/
  7. CMS-3481-P, Hospital Condition of Participation (proposed), 90 FR 59463. https://www.federalregister.gov/documents/2025/12/19/2025-23465/; regulatory agenda entry: https://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202510&RIN=0938-AV87
  8. United States v. Skrmetti, 605 U.S. 495 (2025). https://supreme.justia.com/cases/federal/us/605/23-477/; CRS LSB11329: https://www.congress.gov/crs-product/LSB11329
  9. H.R. 3492, 119th Cong. https://www.congress.gov/bill/119th-congress/house-bill/3492
  10. (Removed in v0.2. This was a law-firm summary used in place of the rule's own text.)
  11. interACT, National and State Legislation on Intersex. https://interactadvocates.org/intersex-legislation-regulation/
  12. H.R. 10426 (118th), Protect Intersex Children Act. https://www.govtrack.us/congress/bills/118/hr10426
  13. H.R. 5730 (117th). https://www.congress.gov/bill/117th-congress/house-bill/5730/all-info
  14. AAP, Circumcision Policy Statement, 130 Pediatrics 585 (2012), now expired. https://publications.aap.org/pediatrics/article/130/3/585/30235/Circumcision-Policy-Statement
  15. Leibowitz et al., Health Affairs (2012), payer coverage. https://www.healthaffairs.org/doi/10.1377/hlthaff.2011.0776
  16. Journal of Pediatric Urology (2023), Florida Medicaid / 12-state list. https://www.sciencedirect.com/science/article/abs/pii/S1477513123002073
  17. Religious Freedom Restoration Act, 42 U.S.C. § 2000bb et seq. https://uscode.house.gov/view.xhtml?req=%2242+USC+2000bb%22
  18. Burwell v. Hobby Lobby, 573 U.S. 682 (2014). https://www.law.cornell.edu/supremecourt/text/13-354

13. How the citations were checked

This document was researched with Anthropic's Claude, an AI model. To be clear about how much each citation can be trusted:

Checked with web search (Nov. 9, 2026). Claude searched for each item below. In most cases it relied on summaries of search results, not on reading the full primary document: STOP FGM Act (Pub. L. 116-309); United States v. Nagarwala; EO 14187 and the status of PFLAG v. Trump; United States v. Skrmetti; the CMS Medicaid/CHIP final rule (date, docket, effective date); the status of CMS-3481-P; the status of H.R. 3492; the Protect Intersex Children Act (H.R. 5730, H.R. 10426); RFRA § 2000bb-3; the expiration of the AAP circumcision statement; state Medicaid coverage counts for circumcision.

Not confirmed against the primary text. The exact wording of the intersex/DSD exception in the CMS Medicaid/CHIP final rule. The Federal Register and eCFR websites blocked automated access, so this claim rests only on news and advocacy-group reporting.

Not checked with web search; cited from the AI's background knowledge only: Schloendorff v. Society of N.Y. Hospital; Canterbury v. Spence; Meyer v. Nebraska; Pierce v. Society of Sisters; Parham v. J.R.; Troxel v. Granville; Prince v. Massachusetts; Employment Division v. Smith; Fulton v. Philadelphia; Tandon v. Newsom; United States v. Virginia; Bolling v. Sharpe; Pennhurst State School v. Halderman; South Dakota v. Dole; NFIB v. Sebelius; New York v. United States; Printz v. United States; Murphy v. NCAA; Gonzales v. O Centro; Matter of Kasinga; 42 C.F.R. §§ 482.13(b), 482.51(b); Feinberg, "The Child's Right to an Open Future" (1980). These are well-known authorities, but their holdings as characterized here, and any pin cites, have not been checked against the source.

License

The framework is released under the GNU Affero General Public License v3.0; see LICENSE.


Changelog

  • v0.3 (2026-11-09): Clarified the byline so it accurately describes who did the research, drafting, direction, and review.
  • v0.2 (2026-11-09): Removed the law-firm summary previously used in place of the CMS rule's text. Added §13, disclosing which citations were checked with web search and which come from the AI's background knowledge. Changed the license to AGPL-3.0.
  • v0.1 (2026-11-09): First draft. Checked by web search: STOP FGM Act, Nagarwala, EO 14187 and PFLAG status, Skrmetti, CMS Medicaid/CHIP final rule, CMS-3481-P status, H.R. 3492, Protect Intersex Children Act, RFRA § 2000bb-3, AAP statement status, Medicaid coverage counts.
Downloads last month
49